BioXcel Therapeutics Inc (NASDAQ:BTAI)
| 14.27 Delayed Data As of Jul 01 |  +1.07 / +8.11%Today’s Change | 8.80 Today|||52-Week Range 36.49 | -29.81% Year-to-Date |
Latest BTAI News | Press Releases
No recent news for BioXcel Therapeutics Inc.
Today’s Trading
| Previous close | 13.20 |
| Today’s open | 13.05 |
| Day’s range | 12.98 - 14.59 |
| Volume | 773,083 |
| Average volume (3 months) | 755,686 |
| Market cap | $400.5M |
Data as of 3:59pm ET, 07/01/2022
Growth & Valuation
| Earnings growth (last year) | -6.99% |
| Earnings growth (this year) | -14.59% |
| Earnings growth (next 5 years) | +294.10% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.81 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ADMAADMA Biologics Inc | +0.05 | +2.53% |
| KODKodiak Sciences Inc | +0.11 | +1.44% |
| BNGOBionano Genomics Inc | -0.04 | -2.90% |
| ---- |
Data as of 4:00pm ET, 07/01/2022
Financials
| Next reporting date | August 9, 2022 |
| EPS forecast (this quarter) | -$1.18 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$106.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters New Haven, Connecticut |
Forecasts
